Invictus MD Strategies Corp. Announces Closing of Amalgamation Agreement and Private Placement
The Company also submitted final listing documentation to the Canadian Securities Exchange ("CSE") today. Subject to final approval of the CSE, the Company expects its shares to begin trading on the CSE prior to market open on Tuesday, December 23rd.
Except for statements of historical fact, this news release contains certain "forward‐looking information" within the meaning of applicable securities laws. Forward‐looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward‐looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward‐looking statements, including, among others, whether a listing on the CSE will be accepted. The Company undertakes no obligation to update forward‐looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward‐looking statements. More detailed information about potential factors that could affect projected results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company.
Dan Kriznic, Chief Executive Officer & Director
Invictus MD Strategies Corp. and will be trading on the Canadian Securities Exchange on Tuesday December 23 under the symbol IMD